Screener
Rhythm Pharmaceuticals, Inc. RYTM Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCash.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
| Restricted cash | 601 | 522 |
| Other long-term assets | 2,518 | 3,286 |
| Total assets | $442,316 | $480,196 |
| Liabilities, Convertible Preferred Stock and Stockholders’ equity | ||
| Current liabilities: |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s restricted cash?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported restricted cash of $601K in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s restricted cash changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s restricted cash increased by 29.5% year-over-year, from $464K to $601K.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s restricted cash has grown at a 5.3% compound annual growth rate (CAGR), from $403K to $522K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude